Wayne Paris

Wayne Paris

Auto-generated profile, based on publicly available information

Wayne Paris

Abilene Christian University

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2018 in Xenotransplantation
Verified
Journal Article
Closed access
PDF file
WPWayne Paris
Wayne Paris
RSRabbi Jerry H. Seidler
Rabbi Jerry H. Seidler
KFKevin FitzGerald
Kevin FitzGerald
APAasim I Padela
Aasim I Padela
ECEmanuele Cozzi
Emanuele Cozzi
DCDavid Cooper
David Cooper

19 January 2020 in Xenotransplantation
Verified
Journal Article
Closed access
PDF file
CMChace Mitchell
Chace Mitchell
ALAlan Lipps
Alan Lipps
LPLuz Padilla
Luz Padilla
ZWZoie Werkheiser
Zoie Werkheiser
DCDavid Cooper
David Cooper
WPWayne Paris
Wayne Paris

30 July 2020 in Kidney360
Verified
Journal Article
Open access
PDF file
LPLuz Padilla
Luz Padilla
DHDaniel Hurst
Daniel Hurst
RLRaymond Lopez
Raymond Lopez
VKVineeta Kumar
Vineeta Kumar
DCDavid K.C. Cooper
David K.C. Cooper
WPWayne Paris
Wayne Paris
Background: In addition to governmental regulation and scientific advancements, the World Health Organization requires extensive review of local opinions before initiating clinical trials of xenotransplantation (XTx). The purpose of this study was to assess the attitudes of health care providers and patients regarding XTx.Methods: An anonymous Likert-scale survey regarding attitudes toward XTx was distributed to pre- and post-kidney transplant patients, nephrologists, transplant surgeons, and nurses (“providers”). Patient and provider responses were described and compared. Regression analysis using patients’ responses was performed to identify factors associated with XTx acceptance.Results: Eighty percent (32/40) of providers and 69% (113/163) of patients were agreeable to clinical XTx if the risks and results were likely to be similar to kidney allotransplantation (P<0.05). Kidney providers rated the influence of religious beliefs in medical decisions (45% versus 15%) and genetic engineering (43% versus 25%) as being more important than did patients (P<0.05). A small proportion in both groups (<15%) reported concerns about (1) potential personality changes, (2) how others would interact, (3) a perception of being “less human,” or (4) morals or ethics. Logistic regression found that the odds of patients accepting XTx were greater if they had no religious concerns (OR, 25.10; 95% CI, 2.59 to 243.00), but acceptance was less likely if they were not willing to use XTx as a bridge to allotransplantation (OR, 0.18; 95% CI, 0.51 to 0.70).Conclusions: (1) If outcomes were similar to allotransplantation, XTx support was strong among both providers and patients; (2) providers overestimated the influence of religious beliefs and genetic engineering on patient medical decisions, although religious beliefs are associated with XTx acceptance; (3) XTx use as a bridge to allotransplant was associated with XTx acceptance; and (4) psychosocial concerns were low for either group. Future studies among other communities are warranted to assess if similar attitudes exist.

10 September 2016 in Xenotransplantation
Verified
Journal Article
Closed access
PDF file
WPWayne Paris
Wayne Paris
KJKyeonghee Jang
Kyeonghee Jang
LCLeah Colsch
Leah Colsch
APAli Prus
Ali Prus
RBRuth Bargainer
Ruth Bargainer
DCDavid K.C. Cooper
David K.C. Cooper

1 September 2010 in Progress in Transplantation
Verified
Journal Article
Closed access
WPWayne Paris
Wayne Paris
BNBakr Nour
Bakr Nour
Concern has increasingly been expressed about the growing number of reports of medical personnel participating in the transplantation of human organs or tissues taken from the bodies of executed prisoners, handicapped patients, or poor persons who have agreed to part with their organs for commercial purposes. Such behavior has been universally considered as ethically and morally reprehensible, yet in some parts of the world the practice continues to flourish. The concept of justice demands that every person have an equal right to life, and to protect this right, society has an obligation to ensure that every person has equal access to medical care. Regrettably, the Egyptian system does not legally recognize brain death and continues to allow the buying and selling of organs. For more than 30 years in Egypt, the ability to pay has determined who receives an organ and economic need has determined who will be the donor. As transplant professionals, it is important that we advocate on behalf of all patients, potential recipients, and donors and for those who are left out and not likely to receive a donor organ in an economically based system. Current issues associated with this debate are reviewed and recommendations about how to address them in Egypt are discussed.

1 September 2010 in Progress in Transplantation
Verified
Journal Article
Closed access
WPWayne Paris
Wayne Paris
BNBakr Nour
Bakr Nour
Concern has increasingly been expressed about the growing number of reports of medical personnel participating in the transplantation of human organs or tissues taken from the bodies of executed prisoners, handicapped patients, or poor persons who have agreed to part with their organs for commercial purposes. Such behavior has been universally considered as ethically and morally reprehensible, yet in some parts of the world the practice continues to flourish. The concept of justice demands that every person have an equal right to life, and to protect this right, society has an obligation to ensure that every person has equal access to medical care. Regrettably, the Egyptian system does not legally recognize brain death and continues to allow the buying and selling of organs. For more than 30 years in Egypt, the ability to pay has determined who receives an organ and economic need has determined who will be the donor. As transplant professionals, it is important that we advocate on behalf of all patients, potential recipients, and donors and for those who are left out and not likely to receive a donor organ in an economically based system. Current issues associated with this debate are reviewed and recommendations about how to address them in Egypt are discussed.